Pharmacogenomics

Challenges and Opportunities in Therapeutic Implementation
2. Auflage 2018
ISBN: 978-0-12-812626-4
Verlag: Elsevier Science

Buch, Englisch, 442 Seiten, Format (B × H): 197 mm x 241 mm, Gewicht: 1092 g

Pharmacogenomics: Challenges and Opportunities in Therapeutic Implementation, Second Edition, provides comprehensive coverage of the challenges and opportunities facing the therapeutic implications of pharmacogenomics from academic, regulatory, pharmaceutical, socio-ethical and economic perspectives. While emphasis is on the limitations in moving the science into drug development and direct therapeutic applications, this book also focuses on clinical areas with successful applications and important initiatives that have the ability to further advance the discipline. New chapters cover important topics such as pharmacogenomic data technologies, clinical testing strategies, cost-effectiveness, and pharmacogenomic education and practice guidelines. The importance of ethnicity is also discussed, which highlights phar,acogenomic diversity across Latin American populations.With chapters written by interdisciplinary experts and insights into the future direction of the field, this book is an indispensable resource for academic and industry scientists, graduate students and clinicians engaged in pharmacogenomics research and therapeutic implementation.

Zielgruppe

<p>Scientific researchers in academia and the pharmaceutical industry, as well as health care clinicians. Also, graduate students in pharmaceutical science, pharmacy and health sciences. </p>

Autoren/Hrsg.

Lam, Yui-Wing Francis

Scott, Stuart R.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie

Inhaltsverzeichnis

1. Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications
2. Governmental and Academic Efforts to Advance the Field of Pharmacogenomics
3. Incorporating Pharmacogenomics in Drug Development: Industry and Regulatory Perspectives
4. Translating Pharmacogenomic Research to Therapeutic Potentials
5. Pharmacogenomics in Cancer Therapeutics
6. Pharmacogenomics in Cardiovascular Diseases
7. Pharmacogenomics in Psychiatry Disorders
8. Role of Pharmacogenomics in HIV Infection
9. Role of Pharmacogenomics in Diabetes
10. A Look to the Future: Pharmacogenomics, Pharmacoepigenomics, and System Biology - Data Technologies of Today and Tomorrow
11. The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance
12. Pharmacogenomics in Latin American Population
13. Reactive, Point-of-Care, Pre-emptive and Direct-to-Consumer Pharmacogenomic Testing
14. Economic Evaluation of Pharmacogenomic Testing: Lessons from Psychiatric Pharmacogenomics
15. Pharmacogenomics Education and Clinical Practice Guidelines

Über Autor(innen)

Scott, Stuart R.
Dr. Stuart A. Scott will take on the co-editor role for this second edition. Dr. Scott is an Associate Professor in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, and is the Division Head of Pharmacogenomics at the Sema4 clinical genetic testing laboratory. His research interests include multiethnic pharmacogenomic allele discovery, cytogenomics, and long-read sequencing method development. He is a member of several international genomic medicine and pharmacogenomics consortia, has co-authored Clinical Pharmacogenetics Implementation Consortium (CPIC) practice guidelines, and is a co-investigator of the Mount Sinai Institute for Personalized Medicine (IPM) pharmacogenomics implementation program. In addition, he teaches pharmacogenomics and clinical genetics to genetic counseling students, graduate and medical students, clinical residents, and fellows by lecturing for several courses at Mount Sinai and other institutions.